Showing 1 - 10 of 41
We evaluate the welfare effects of differential pricing, voluntary licensing, and compulsory licensing in the Indian market for oral anti-diabetic (OAD) drugs. This market includes a new class of molecules called DPP-4 inhibitors, all of which are under patent protection in India. The Indian...
Persistent link: https://www.econbiz.de/10013035611
drugs in the wholesale markets. We also find that higher concentration of private retailers amplifies the impact, indicating …
Persistent link: https://www.econbiz.de/10014081925
We argue that greater misallocation is a key driver of the worse management practices in Mexico compared to the US. These management practices are strongly associated with higher productivity, growth, trade, and innovation. One indicator of greater misallocation in Mexico is the weaker...
Persistent link: https://www.econbiz.de/10012938686
Persistent link: https://www.econbiz.de/10013392321
Persistent link: https://www.econbiz.de/10011714400
Persistent link: https://www.econbiz.de/10012060267
Persistent link: https://www.econbiz.de/10012042464
Do upstream research shocks directly and contemporaneously impact related but disconnected downstream product markets? We explore this question using a natural experiment involving the New Delhi Metallo-Beta-Lactamase 1 superbug pathogenic outbreak in India. Using a difference-in-differences...
Persistent link: https://www.econbiz.de/10012533389
This paper examines the relationship between exogenous demand shock and market structure in India’s influenza vaccine markets. Using a novel dataset of detailed purchasing information for vaccines in India, and exploiting the 2009-10 global H1N1 pandemic as an exogenous demand shock, we...
Persistent link: https://www.econbiz.de/10014033643
This paper examines the relationship between exogenous demand shocks and market structure in India’s influenza vaccine markets. Using a novel dataset of detailed purchasing information for vaccines in the country, and exploiting the occurrence of the 2009-10 global H1N1 pandemic as an...
Persistent link: https://www.econbiz.de/10014035294